Search clinical trials for: relapse rate

Total 11978 results

Charite University, Berlin, Germany

Not yet recruiting

Presence and Relapse Rates in Patients With Alcohol Use Disorder Using Virtual Reality (PRE-VR)

Alcohol Dependence

Germany
Worg Biotherapeutics Inc.

Recruiting

Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz

Graves Disease

United States
Assiut University

Not yet recruiting

Gut Microbiota Dysbiosis in Opioid Use Disorders: Implications for Clinical Symptoms and Relapse Rate.

Opioid Use Disorder | Opioid Dependence | Opioid Use
Instituto do Cancer do Estado de São Paulo
Libbs Farmacêutica LTDA

Recruiting

Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia With Failed Remission

Brazil
Chinese SLE Treatment And Research Group

Recruiting

Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)

ANCA-associated Vasculitis | Maintenance Therapy

China
Chinese SLE Treatment And Research Group
Peking Union Medical College Hospital

Recruiting

Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM)

ANCA Associated Vasculitis

China
Universidade do Porto
Fundação para a Ciência e a Tecnologia; Research Centre in Physical Activity...

Recruiting

Is Resistance Exercise More Effective Than Endurance in Reducing Obesity Relapse in Post-bariatric Surgery Patients (BariOptimize)

Bariatric Surgery Patients

Portugal
Hospices Civils de Lyon

Recruiting

Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma (Mel-ImmAdj)

Melanoma

France
Fudan University

Recruiting

R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse

Diffuse Large B-cell Lymphoma

China
Peking Union Medical College Hospital
Henan Cancer Hospital; Qilu Hospital of Shandong University; Beijing Tongren... and other collaborators

Recruiting

Phase II Study of Orelabrutinib Combined With PD-1 Inhibitor in Relapsed/Refractory Primary Central Nervous System Lymphoma

Primary Central Nervous System Lymphoma

China
N.N. Petrov National Medical Research Center of...

Recruiting

HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer

Biochemical Relapse Free Survival | Complications Rates (Erectile Dysfunction, GI, GU Complications)

Russian Federation
Second Affiliated Hospital, School of Medicine,...

Recruiting

Sequential Low-dose Decitabine With PD-1/CD28 CD19 CAR-T in Relapsed or Refractory B-cell Lymphoma

Objective Response Rate

China
John Reneau

Recruiting

Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma

Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Adult T-Cell Leukemia/Lymphoma

United States
Shaheed Zulfiqar Ali Bhutto Medical University

Recruiting

Comparison of Relapse Rate After 12 Weeks Verses 20 Weeks Steroid Therapy for the Management of First Episode of Steroid Sensitive Nephrotic Syndrome

Steroid-Sensitive Nephrotic Syndrome

Pakistan
Fudan University

Recruiting

Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma (Sincerely20)

Peripheral T-cell Lymphoma

China
Assistance Publique - Hôpitaux de Paris

Recruiting

RItuximab From the FIRst Episode of Idiopathic Nephrotic Syndrome (RIFIREINS)

Minimal Change Nephrotic Syndrome (MCNS)

France
Travera Inc
Massachusetts General Hospital; Dana-Farber Cancer Institute; Weill Medical College... and other collaborators

Recruiting

Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma

Multiple Myeloma in Relapse

United States
Regeneron Pharmaceuticals

Active, not recruiting

Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

Relapsed and Refractory Multiple Myeloma (RRMM)

United States
University of Maryland, Baltimore

Active, not recruiting

Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

United States
Shanghai Jiao Tong University School of Medicine

Completed

Flu-Bu-Mel Conditioning Regimen for Myeloid Disease

Relapse Rate After Allo-HSCT

China
Nourhan M.Aly

Completed

Relapse and Failure Rates Between CAD/CAM and Conventional Fixed Retainers

Relapse

United States
AbbVie

Completed

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent). (VENICE II)

Chronic Lymphocytic Leukemia (CLL)

Argentina, Australia, Bulgaria, Hong Kong, Hungary, Mexico, New Zealand, Poland, Russian Federation, Taiwan
Charite University, Berlin, Germany
Eli Lilly and Company

Withdrawn

Optimal Duration of Olanzapine Add-on Therapy in Major Depression (OLA-D)

Relapse Rate of a Major Depressive Episode | Safety of Olanzapine in Subjects With Major Depression

Germany
University of Aarhus
University of Oslo

Active, not recruiting

CAD/CAM Fixed Retainers vs. Conventional Multistranded Fixed Retainers in Orthodontic Patients. Comparison of Stability, Retainer Failure Rate, Adverse Effects, Cost-effectiveness, and Patient Satisfaction. A Randomized Controlled Clinical Trial (Retention)

Relapse

Denmark, Norway
Huashan Hospital

Completed

Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy

Chronic Hepatitis B

China
Cinnagen

Completed

Efficacy and Safety of Xacrel® (Ocrelizumab) in Participants With Relapsing Remitting Multiple Sclerosis

Multiple Sclerosis | Relapsing-Remitting

Iran, Islamic Republic of
Maastricht Radiation Oncology
The Netherlands Cancer Institute; Diakonessenhuis, Utrecht

Completed

Radiotherapy After Primary Chemotherapy for Breastcancer (RAPCHEM)

Breast Cancer

Netherlands
Indiana Kidney Stone Institute
University of Washington; VA Puget Sound Health Care System

Completed

Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney

Ureteral Stones, Kidney Stones

United States
OSF Healthcare System

Completed

Correlation Between Relapses in Multiple Sclerosis (MS) and Vitamin D Intake

Multiple Sclerosis

United States
Assistance Publique - Hôpitaux de Paris

Completed

Evaluation of the Relapse Rate One Month After Discharge From Emergency Department for Asthmatic Patients Given a Strict Formalized Follow up Protocol (ASUR-R)

Asthma

France
Centre Leon Berard

Completed

Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics) (SBRT)

Ependymoma | Brain Metastasis | Lung Tumors | Spinal Tumors

France
Canadian Myeloma Research Group

Completed

A Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma

Multiple Myeloma in Relapse

Canada
Northwestern University

Completed

Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes

Pregnancy | Labor Pain

United States
M.D. Anderson Cancer Center
Sanofi

Completed

Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Leukemia | Transplantation Infection | Disorder Related to Bone Marrow Transplantation

United States
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; M.D. Anderson Cancer Center; Merck Sharp & Dohme LLC; Dana-Farber Cancer Institute and other collaborators

Completed

Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors

Solid Tumors | Relapsed/Refractory Sarcomas

United States, Canada
Cinnagen

Completed

Safety and Effectiveness of Cinnomer® (Glatiramer Acetate) in Multiple Sclerosis (MS) Treatment in Iran

Relapsing Multiple Sclerosis
Children's Hospital of Fudan University

Completed

Study on Chinese and Western Medicine in MNE Children

Monosymptomatic Nocturnal Enuresis

China
Isfahan University of Medical Sciences

Completed

Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients

Neuromyelitis Optica Spectrum Disorder

Iran, Islamic Republic of
Lund University Hospital
Celgene; Janssen, LP; Nordic Lymphoma Group

Completed

A Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma (PHILEMON)

Relapsed/Refractory Mantle Cell Lymphoma

Finland, Denmark, Sweden, Norway
Therapeutic Advances in Childhood Leukemia Consortium
Genzyme, a Sanofi Company

Terminated

T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML)

Relapsed Acute Myelogenous Leukemia

United States
Carlos Graux, MD, PhD
Celgene Corporation; Belgian Hematological Society

Completed

Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.

Myelodysplastic Syndrome | Acute Myelogenous Leukemia

Belgium
Holy Name Medical Center, Inc.
Biogen

Unknown

Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects

Multiple Sclerosis

United States
KU Leuven
Research Foundation Flanders

Completed

Influence of Oxytocin on Neurophysiological Responses to Live Faces

Oxytocin

Belgium
Dana-Farber Cancer Institute
Eli Lilly and Company

Terminated

Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial

Acute Myeloid Leukemia | Myelodysplastic Syndromes

United States
Isfahan University of Medical Sciences

Completed

Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients

Secondary Progressive Multiple Sclerosis

Iran, Islamic Republic of
City of Hope Medical Center

Withdrawn

Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas

Sezary Syndrome | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Mycosis Fungoides | Folliculotropic Mycosis Fungoides | CD30-Positive Neoplastic Cells Present | Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma

United States
Centre Leon Berard

Terminated

BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT) (BENEFIT)

Follicular Lymphoma

France
Chang Gung Memorial Hospital

Completed

Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy

Erosive Esophagitis

Taiwan
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer

Testicular Germ Cell Tumor | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Extragonadal Germ Cell Tumor

United States
Rutgers, The State University of New Jersey
Nepalese Psychological Association; New Jersey Psychological Association

Completed

A Cognitive Behavioral Stress Intervention for Women Who Smoke

Smoking Cessation | Stress | Stress, Emotional | Smoking, Cigarette | Stress Reaction

United States

Search clinical trials for: relapse rate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations